Ownership history in Mariner, LLC · 2 quarters on record
This page tracks every 13F SEC filing in which Mariner, LLC reported a position in LIGAND PHARMACEUTICALS INC (LGND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,537 | -1,037 | -40.3% | 0.00% | $272K | $177.14 |
| 2024 Q4 | INITIATED | 2,574 | — | — | 0.00% | $276K | $107.15 |
As of 2025 Q4 — sorted by position size